Followers
0
Following
1
Blog Posts
0
Threads
31
Blogs
Threads
Portfolio
Follower
Following
2 months ago | Report Abuse
简单来说
genm和rav合资bb Entertainment’s genm 78% rav 22%
2012到2022 一共亏了700m usd
rav认为账目不清楚 不爽亏了那么多钱 所以sue genm要求600m usd赔偿。
这个新闻都是rav一方面的说法。
genm没有包输这个600m 除非账目真的有问题 而且要赔多少钱还是要法官判
如果账目没有问题,genm把bb卖了只要输700m的78%。这些输的钱早在以前的账目已经记录了。 对未来的账目不会有影响。
#做生意本来都没有包赢的 rav要包赢。
#纯属看了新闻后的看法 有错请更正
2024-09-19 21:24 | Report Abuse
下个季度和后个季度就可以看到答案 加上年尾taurx可能会成功 相信未来是好的
2024-09-19 21:09 | Report Abuse
@Michaelchan2024
By reducing its debt load, Genting can lower its annual interest payments. With debt reductions of this magnitude, the interest savings could be substantial. The interest savings from this debt reduction could result in an annual recurring saving of as much as RM250 million..
加上fed降息0.5% 是不是可以每年省下150m?
2024-09-18 20:25 | Report Abuse
马币从7月开始起了10% 有没人可以estimate下个季度GB外汇盈利是多少
2024-09-09 01:32 | Report Abuse
Aiya not many believers of Taurx here anyway. Most believe in steep NTA discounts, scams like rm2.5b forex gains in Q3's P&L, lowering of net debt in 2024/2025/2026, cheap roll over of ZIRP era USD debts upon expiry etc.
Real believers of Taurx would have bought Taurx shares directly instead of buying GenB. Im not promoting Taurx these days but its not fair to do Taurx bashing until Christmas season show is over and Taurx fails to secure UK approval.
@atk,bro,how to buy taurx shares?
2024-08-30 00:12 | Report Abuse
The American grandsons ER and RWLV are not performing. Huge billions of USD loans at high interest keep sucking away RWG (monopoly) and RWS (duopoly) hard-earned profits.
totally agreed....rwlv very头痛
2024-07-30 23:56 | Report Abuse
When the MHRA has received your documents and validated them, we will contact to you within 5 working days to confirm that the 60-day assessment period has started, or we will let you know if there are any issues. If there are any issues raised, the 60-day assessment period will start when we receive a valid response.
Day 1 of the 60 days is taken as being the first day that follows the date of acceptance of a valid application. For example, if an application is received on 24 August and the assessor validates the submission on 28 August, the clock starts on 29 August.
During the assessment, experts will assess the safety and performance of your device as well as the design of the clinical investigation to be carried out. The MHRA will write to you if we require further information. It is essential that you contact the MHRA as soon as possible if you require clarification. If there are possible grounds for objection, where possible we will arrange a teleconference for a better understanding and to find a resolution within the 60-day assessment time.
A letter will be sent to you by the 60th day with a decision (‘objection’ or ‘no objection’) as to whether or not you can carry out the proposed clinical investigation.
2024-07-29 00:30 | Report Abuse
@AngTayKor, I have deleted the link to that important USA based medical paper endorsed by leading USA agencies, ex-FDA Neuro Chief and KOLs, lest the jealous will accuse ATK of conning investors with Taurx news. There are several very good points in that paper that will be used and cited in our submissions to FDA hence it is sensitive info.
@AngTayKor bro can share again pls?
2024-07-17 14:20 | Report Abuse
thank you...
urm...wat is AA ah?,,,hahaha
2024-07-17 13:52 | Report Abuse
hi bro @AngTayKor
did u know the latest news of taurx with fda type c meeting?they still not yet meeting right?
2024-05-22 13:59 | Report Abuse
@dragon328,wat ur estimation pfofit in upcoming qr?
2024-05-21 10:54 | Report Abuse
我打算要起诉serbadk。
有人要一起吗?
2024-05-15 01:02 | Report Abuse
malaysia big investor Chua Ma Yu buy 22m unit in 2022,10m unit in 2023.成为第10大股东,他的买入100%不会低过4快。现在才4.7
2024-03-10 09:14 | Report Abuse
who can give the link of IB maybank report pls?
Stock: [GENTING]: GENTING BHD
1 month ago | Report Abuse
2024: A possible treatment
awaits regulatory approval
TauRx’s product, HMTM, has been submitted to the UK's Medicines and Healthcare products Regulatory Agency (MHRA) as a tablet to treat MCI and mild to moderate stages of Alzheimer’s disease. A decision is expected by the end of the year.
TAURX website updates new look.